Tempus AI, Inc. - Class A Common Stock (TEM)

On Thursday, Cathie Wood-led Ark Invest made significant trades involving Tempus AI Inc. (NASDAQ:TEM), Coinbase Global Inc. (NASDAQ:COIN), Robinhood Markets Inc. (NASDAQ

An AI health care stock backed by Nancy Pelosi and Cathie Wood is drawing criticism from Jim Cramer.

Apple's $60 billion cash pile and a rare executive shake-up reignite speculation: will the tech giant finally go on an AI buying spree to catch up with rivals?

Jim Cramer advises against investing in Tempus AI due to its ongoing losses and suggests Pan American as a profitable alternative. Insmed is also considered speculative while the only viable option for autonomous vehicles is Tesla. Ouster's stock was downgraded and other companies experienced mixed price action.

On Wednesday, the Cathie Wood-led Ark Invest made a significant move by purchasing a substantial number of shares in Tempus AI Inc. (NASDAQ:TEM) and selling shares of Block Inc. (NYSE:XYZ).

Cathie Wood's Ark Investment Management has filed plans to launch four new exchange-traded funds designed to offer downside protection for investors in its flagship ARK Innovation ETF (BATS: ARKK), while placing a cap on potential gains.

10 worst performing large-cap stocks in holiday-shortened week, including Centene Corp, Molina Healthcare, and Circle Internet Group.

BofA analysts review the promise and limits of AI in precision medicine, highlighting key players like Tempus, Guardant, and Exact Sciences.

"It's the volatility that attracts traders," Matt Markiewicz, head of Product and Capital Markets at Tradr, told Benzinga.

TEMPUS AI (NASDAQ:TEM) is a high-growth healthcare tech stock meeting Minervini's Trend Template with strong revenue growth, earnings beats, and a perfect technical rating of 10/10.

Top 10 large-cap stocks with biggest gains last week: INSM, CRCL, ORCL, ASTS, SAIL, VG, TEM, CASY, EQNR, HAL. Have you invested in them?

Cathie Wood argues that AI will create more jobs than it displaces, and predicts a radical change in traditional corporations. Her thesis aligns with ARK Invest's investments in chipmakers and software firms.

Members of Congress are trading less than usual in 2025 but haven't completely given it up; this is a look at who traded what in the first half.

The company stated that the assay, currently available for research use, will be clinically available later this year.

Tempus AI Inc (NASDAQ:TEM) shares are moving higher Monday after the company introduced a new program to monitor immunotherapy response for patients with advanced cancer.